Evidence map›Paper›PMID 41291917›Full record

ArticleRadiation oncology (London, England)2025

Periventricular radionecrosis after conventionally fractionated radiation for low grade meningiomas.

Cecilia Jiang, Tara McWilliams, Melanie Berger, Emily S Lebow, Harper Hubbeling, Elizabeth Azar, James D Kolker, Suneel N Nagda, Goldie Kurtz, Jennifer Wei Zou and 3 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Obstacles and Trials in Treating Primary Brain Tumors.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cecilia JiangDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA. jiangcec@gmail.com.
Tara McWilliamsCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Melanie BergerDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Emily S LebowDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Harper HubbelingDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Elizabeth AzarDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
James D KolkerDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Suneel N NagdaDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Goldie KurtzDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Jennifer Wei ZouDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Ryan ScheuermannDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Ajay KumarDivision of Neuroradiology, University of Pennsylvania, Philadelphia, PA, USA.
Michelle Alonso-BasantaDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadionecrosis (RN) is a serious late complication of radiotherapy (RT). While its risk is well characterized after stereotactic radiosurgery, RT dose thresholds for development of RN following conventionally fractionated RT (CFRT) are poorly defined; in the periventricular region, the risk of RN has not been systematically investigated. Our study objectives are therefore to estimate the incidence of periventricular white matter radionecrosis (PVRN) following CFRT for low grade meningiomas and identify associated clinical and dosimetric predictors. We chose a cohort of low-grade meningiomas (World Health Organization grade I–II) for this purpose because of their low recurrence risk, thus minimizing diagnostic uncertainty between RN and progression.

methodsThis is a single-institution retrospective analysis of 135 adult patients who received CFRT between June 2011 and March 2023. The periventricular white matter was retrospectively contoured and dosimetric details to this region were extracted. PVRN was radiographically diagnosed and graded using Common Terminology Criteria for Adverse Events (CTCAE v5.0). Univariate analysis was performed to assess associations between PVRN and clinical or dosimetric variables. Logistic regression using restricted cubic splines and segmented models was used to identify dosimetric constraints predictive of PVRN.

resultsMedian RT dose was 59.4 Gy (Gy) in 33 fractions; median follow-up was 66.5 months (range 1-151 months). 15% (n = 20) developed RN, with 11% (n = 15) PVRN and 6% (n = 8) grade 2 + PVRN. Overlap between the planning target volume and periventricular structures, as well as multiple high-dose constraints, were significantly associated with PVRN. V55 Gy to the periventricular substructure was the strongest predictor for both any-grade and grade 2 + PVRN; between 0 and 8 cc, V55 Gy values of 2.7, 3.6, and 4.8 cc were associated with < 5%, < 10%, and < 20% risk of grade 2 + PVRN, respectively. After excluding patients with prior cranial RT, V55 Gy remained the most predictive constraint with cutoff values of 2.7 and 3.1 cc associated with < 5% and < 10% risk of grade 2 + PVRN.

conclusionsOverlap with the periventricular region is associated with risk of symptomatic RN among patients receiving conventionally fractionated radiotherapy.

Indexed as

Meningeal NeoplasmsMeningiomaRadiation InjuriesWhite MatterAdultAgedAged, 80 and overDose Fractionation, RadiationFemaleHumansMaleMiddle AgedNecrosisRadiosurgeryRadiotherapy DosageRetrospective StudiesConventional fractionationDosimetric predictorsMeningiomaPeriventricularRadionecrosis

Identifiers

PMID41291917
PMCPMC12648850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.